Physician profile
Robert M Olson, III
NPI 1881079119
$356.66
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $43.75 · 2022: $62.13.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $128.27 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $64.87 | 2019 | |
| Kaleo, INC. | $46.15 | 2019 | |
| Uswm, LLC | $37.82 | 2022 | |
| Mdd US Operations, LLC | $32.05 | 2019-2020 | |
| Alkermes, INC. | $24.31 | 2022 | |
| Emergent Biosolutions INC. | $23.19 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Olson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.